Metraipolis › archive › dc_4e2b0d7e1e5d

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty — Europe PMC PMID:42564874

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42564874
DOI
10.3389/fimmu.2026.1796161
License (as archived)
solo-consultazione
Archived
2026-10-08T14:44:16.765Z
SHA-256 of the archived text
fb6c090d3fe55c5186b2ee168bdc01066cc9664d8c110e8005e30fee724d1244
Stable URL of this page
https://metraipolis.com/documento/dc_4e2b0d7e1e5d

How to cite

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty — Europe PMC PMID:42564874 — Europe PMC (en), https://europepmc.org/article/MED/42564874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e2b0d7e1e5d (Metraipolis archive dc_4e2b0d7e1e5d, sha256 fb6c090d3fe55c5186b2ee168bdc01066cc9664d8c110e8005e30fee724d1244)
BibTeX
@misc{dc4e2b0d7e1e5d,
  title = {Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty — Europe PMC PMID:42564874},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42564874},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e2b0d7e1e5d; sha256 fb6c090d3fe55c5186b2ee168bdc01066cc9664d8c110e8005e30fee724d1244},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42564874. Agents can read the archived copy with the MCP tool read_document.